Clinical Trial Update: Use of Erythromycin in Mustard-Induced Bronchiolitis [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed erythromycin for mustard-induced bronchiolitis obliterans and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Drugs mentioned

• ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Baqiyatallah Medical Sciences University | Conditions: Bronchiolitis Obliterans, Acute Obliterating Bronchiolitis | Phase 4 | Status: COMPLETED